Media Reports on Michael Nelson, MD, PhD’s Work on an FDA Committee

June 8, 2022 by pmb3fz@virginia.edu

Asthma, Allergy and Immunology Division Chief Michael Nelson was one of the vaccine advisers to the US Food and Drug Administration who decided  that authorizing Novavax’s Covid-19 vaccine – which uses different technology from the three vaccines currently in use in the US – for emergency use in adults would be beneficial.

Read the story on CNN.

Filed Under: Media Highlights, Research